Bioprocessing Conference
2020-12-03
Online
Online
10:00
- 10:10
Welcome Address
Dr Jonathan Downey
Managing Director - ARTeSYN BioSolutions
10:15
- 10:25
Opening Remarks
Martin Shanahan
CEO, IDA
10:30
- 11:30
Plenary Session
Challenges facing the industry as technology develops at a rapid pace and new techniques are adopted. International perspectives on the future of the Irish biopharma sector in a post-Covid-Brexit world.
Barry Kennedy
CEO, Irish Manufacturing Research / Panel Moderator
Brendan McGrath
Brendan McGrath - Site Head and Vice President of Manufacturing - WuXi Biologics
Christine Gebski
Vice President, Product Management & Field Applications - REPLIGEN CORPORATION
Paul Keogh
Plant Director, Takeda Ireland
Rory Mullen
Head of Biopharma, IDA
Gary Hartnett
General Manager/VP - Janssen Sciences Ireland
11:40
- 12:00
Vaccines & COVID19
Professor Luke O’Neill
Chair of Biochemistry - Trinity College Dublin
12:05
- 12:25
Single use technologies
Jim Vogel
Founder & DIrector The BioProcess Institute
12:25
- 12:45
Cell & Gene Therapies
Dr Nina Bauer
Head of Commercial Gene Editing & Novel Modalities Business, ,Merck
12:45
- 13:00
Increasing lentiviral vector bioreactor yield with simplified execution using tangential flow depth filtration
Michael Bransby
Research and Development Director of Process Technology, Repligen
13:10
- 14:10
Panel Discussion – Addressing Future Skills Needs for the BioPharma Sector
Matt Moran
Director - BioPharmaChem Ireland /Panel Moderator
Paul Healy
Chief Executive, Skillnet Ireland
Barry Curry
Director of Project Management - Système
Dr. Ramesh Raghavendra
Centre Director & Founder of 3DWIT - SEAM
Geoffrey Allen
Imagineer - Mersus Technologies
Darrin Morrissey
CEO - NIBRT
Dr. Thomas Becker
Director Site Quality - Recipharm, Wasserburger Arzneimittelwerk GmbH
14:15
- 15:00
Panel Discussion – Game Changers – BioPharma and the Sustainability Challenge
David McCormack
Director, Sustainable Manufacturing, IMR / Panel Moderator
Daniel Howell
European RTC Manager, STERIS
Timmy Carey
Associate Director EHS&S - BioMarin Pharmaceutical Inc.
Inder Poonaji
Founder - Six Butterflies
Cian O’Brien
Head of Innovation, Digital & Engineering at Sanofi
15:05
- 16:05
Panel Discussion – Business Transformation – The Digital BioPharma Opportunity
Siobhan Fleming
Business Development Manager, Siemens / Panel Moderator
Emily Mitchell
Executive Director, Biometrics - PRAHS
David Kelaher
Chief Medical Officer - Pharmaspectra
Peter R. Levison
Executive Director Business Development - Pall Biotech
Dr Paul Dobson
Head of Data - Valitacell Ltd
Barry Curry
Director of Project Management - Système
16:10
- 16:30
Ireland, a global example for FDI
Professor Gerry Byrne
Managing Director - GB Innovation.
16:30
- 16:45
Closing Remarks
Dr Jonathan Downey
Managing Director - ARTeSYN BioSolutions
Select date to see events.